The tariff classification of the LiRIS® (Lidocaine Releasing Intravesical System)
Reasoning
The tariff classification of the LiRIS® (Lidocaine Releasing Intravesical System)
Cite this ruling
CBP Ruling N285491 (3004909245): The tariff classification of the LiRIS® (Lidocaine Releasing Intravesical System)
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of ML8054, imported in bulk and capsule forms, from Canada and the United Kingdom
The tariff classification of Tolevamer (code designation: GT267-004), imported in bulk form; Tolevamer 7% Oral Solution, imported put up in 45 mL single-use bottles; and Tolevamer 7% Oral Solution Placebo, imported put up in 45 mL single-use bottles, from Ireland and the United Kingdom
The tariff classification of Stryker® TCP Putty from Ireland
The tariff classification of Bortezomib (CAS-179324-69-7), imported in bulk form, and VELCADE® (bortezomib) for Injection, from Canada and the United Kingdom
The tariff classification of BETAGAN® (levobunolol hydrochloride ophthalmic solution, USP) 0.5%, supplied in 10mL and 15mL plastic bottles with dropper tips and screw-down caps.